本页面由Tiger Trade Technology Pte. Ltd.提供服务

Amylyx Pharmaceuticals

14.11
-1.1900-7.78%
成交量:135.69万
成交额:1,957.75万
市值:15.60亿
市盈率:-7.95
高:15.70
开:15.42
低:13.75
收:15.30
52周最高:17.49
52周最低:2.60
股本:1.11亿
流通股本:6,544.94万
量比:1.13
换手率:2.07%
股息:- -
股息率:- -
每股收益(TTM):-1.7742
每股收益(LYR):-4.4281
净资产收益率:-56.52%
总资产收益率:-39.44%
市净率:4.70
市盈率(LYR):-3.19

数据加载中...

2026/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/03

重要事件披露

Form 8-K - Current report
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

重要事件披露

Form 8-K - Current report
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities